AUTOANTIBODY TO THE ALTERNATIVE PATHWAY C3/C5 CONVERTASE AND ITS ANTIIDIOTYPIC RESPONSE - A STUDY IN AFFINITY

被引:0
|
作者
SPITZER, RE
STITZEL, AE
TSOKOS, GC
机构
[1] NIH,BETHESDA,MD 20892
[2] UNIFORMED SERV UNIV HLTH SCI,DEPT MED,BETHESDA,MD 20892
来源
JOURNAL OF IMMUNOLOGY | 1992年 / 148卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In an effort to understand the development and control of autoantibody production, we studied the affinity of autoantibody to the alternative pathway C3/C5 convertase (C3 nephritic factor (C3NeF)) and its autoanti-idiotypic antibodies, Ab2-alpha and Ab2-beta. These were isolated and purified from newborns, normal adults, and patients with membranoproliferative glomerulonephritis. In all cases, both IgG and IgM C3NeF were available for study. The affinity of IgG and IgM C3NeF for their natural Ag (10(8) liters/mol) as well as for the internal image of that Ag displayed on Ab2-beta was high (10(10) liters/mol). Furthermore, the affinity of IgG C3NeF was nearly 100-fold higher in patients than in newborns, whereas there were no significant changes with IgM C3NeF. By contrast, there were no differences in the affinity of IgG Ab2-alpha (which does not display any likeness to the native Ag) from normal adults and patients to any C3NeF isolate. There was, however, a progressive increase in affinity between both Ab2-alpha preparations and IgG C3NeF from newborns, adult normal subjects, and patients, implying an alteration in C3NeF to account for the changes in affinity. These data suggest that Ag-driven affinity maturation occurs with autoantibody but may not occur within the idiotypic network. These data also indicate that as autoantibody affinity matures, it appears to modify its idiotype, perhaps in an effort towards autoregulation.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 50 条
  • [1] C3 REQUIREMENTS FOR FORMATION OF ALTERNATIVE PATHWAY C5 CONVERTASE
    DAHA, MR
    FEARON, DT
    AUSTEN, KF
    [J]. JOURNAL OF IMMUNOLOGY, 1976, 117 (02): : 630 - 634
  • [2] ADDITIONAL C3 REQUIREMENT FOR ALTERNATIVE PATHWAY C5 CONVERTASE
    DAHA, MR
    FEARON, DT
    AUSTEN, KF
    [J]. FEDERATION PROCEEDINGS, 1976, 35 (03) : 654 - 654
  • [3] NUCLEOTIDE-SEQUENCE OF A HUMAN AUTOANTIBODY TO THE ALTERNATIVE PATHWAY C3/C5 CONVERTASE (C3NEF)
    VICTOR, KD
    PASCUAL, V
    STITZEL, AE
    TSOKOS, GC
    CAPRA, JD
    SPITZER, RE
    [J]. HYBRIDOMA, 1993, 12 (03): : 231 - 237
  • [4] HUMAN ANTIIDIOTYPIC ANTIBODY-RESPONSES TO AUTOANTIBODY AGAINST THE ALTERNATIVE PATHWAY C3 CONVERTASE
    SPITZER, RE
    STITZEL, AE
    TSOKOS, GC
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 57 (01): : 19 - 31
  • [5] Functional characterization of alternative pathway C3 and C5 convertase inhibitors
    Gorham, Ronald D., Jr.
    Zwarthoffl, Seline A.
    Xue, Xiaoguang
    Ruyken, Maartje
    Jozsi, Mihaly
    Grose, Piet
    Rooijakkers, Suzan H. M.
    [J]. MOLECULAR IMMUNOLOGY, 2017, 89 : 141 - 141
  • [6] STUDY OF THE IDIOTYPIC RESPONSE TO AUTOANTIBODY TO THE ALTERNATIVE PATHWAY C3/C5 CONVERTASE IN NORMAL INDIVIDUALS, PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, AND EXPERIMENTAL-ANIMALS
    SPITZER, RE
    STITZEL, AE
    TSOKOS, GC
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 62 (03): : 291 - 294
  • [7] C3/C5 convertase of the lectin pathway of complement
    Rawal, N
    [J]. MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 300 - 300
  • [8] THE C3/C5 CONVERTASE OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - STABILIZATION AND RESTRICTION OF CONTROL BY LANTHANIDE IONS
    FISHELSON, Z
    MULLEREBERHARD, HJ
    [J]. MOLECULAR IMMUNOLOGY, 1983, 20 (03) : 309 - 315
  • [9] TRYPANOSOMA-LEWISI - RESTRICTION OF ALTERNATIVE COMPLEMENT PATHWAY C3/C5 CONVERTASE ACTIVITY
    STURTEVANT, JE
    BALBER, AE
    [J]. EXPERIMENTAL PARASITOLOGY, 1987, 63 (03) : 260 - 271
  • [10] EVIDENCE THAT PRODUCTION OF AUTOANTIBODY TO THE ALTERNATIVE PATHWAY C3 CONVERTASE IS A NORMAL PHYSIOLOGICAL EVENT
    SPITZER, RE
    STITZEL, AE
    TSOKOS, GC
    [J]. JOURNAL OF PEDIATRICS, 1990, 116 (05): : S103 - S108